Stay updated on STX209 Effects in ASD Clinical Trial
Sign up to get notified when there's something new on the STX209 Effects in ASD Clinical Trial page.

Latest updates to the STX209 Effects in ASD Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.1.SummaryDifference1%
- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check57 days agoChange DetectedThe webpage has been updated to include new details about a study on STX209 for Autism Disorder, including the dosing regimen and collaborators, while removing extensive background information on the study's rationale and methodology.SummaryDifference24%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to STX209 Effects in ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STX209 Effects in ASD Clinical Trial page.